Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20
What Is The Future Market Size Estimation For The Prothrombin Complex Concentrate Market Covering 2025–2034?
The prothrombin complex concentrate market size has exhibited substantial growth in recent years. This market is projected to expand from $1.29 billion in 2024 to $1.38 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 6.7%. The historical expansion can be attributed to several factors, including an increase in the prevalence of bleeding disorders, heightened use in warfarin reversal, a growing awareness of coagulation therapies, the expansion of surgical procedures, and an uptick in trauma cases.
The prothrombin complex concentrate market is anticipated to experience substantial expansion in the coming years. It is projected to reach $1.83 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 7.3%. This growth during the forecast period is primarily driven by the increasing demand for rapid coagulation therapies, the rising prevalence of hemophilia and liver diseases, greater adoption in emergency medicine, expanding applications in cardiac surgeries, and growing healthcare expenditure. Furthermore, significant trends expected in this period include the integration of AI-driven diagnostics, advancements in recombinant coagulation factors, the emergence of next-generation recombinant pccs, customized dosing algorithms, and further advancements in blood plasma products.
Unlock Your Free Sample Report for Exclusive Market Data:
https://www.thebusinessresearchcompany.com/sample.aspx?id=23488&type=smp
Which Drivers Are Impacting The Prothrombin Complex Concentrate Market?
The growing occurrence of bleeding disorders is anticipated to drive the expansion of the prothrombin complex concentrate market. These medical conditions involve blood that does not clot effectively, resulting in excessive bleeding due to absent or malfunctioning clotting factors or platelets. The increase in bleeding disorders is largely due to the rising prevalence of genetic conditions such as hemophilia, a surge in liver disease cases, the growing use of anticoagulant medications, and a higher incidence of vitamin K deficiencies. Prothrombin complex concentrate effectively treats these disorders by rapidly replenishing crucial clotting factors necessary for proper blood coagulation and hemostasis. For example, in November 2023, the National Library of Medicine, a U.S.-based medical library, stated that a 2022 study involving 10,276 individuals with hemophilia was carried out across 87 treatment centers in 40 countries. The findings indicated that nearly 49% of the participants had severe hemophilia, 99% were male, and 85% were diagnosed with hemophilia A. Additionally, 67% of the patients were from low- and middle-income countries. This demonstrates that the increasing prevalence of bleeding disorders is indeed fostering the growth of the prothrombin complex concentrate market.
What Are The Major Segment Categories Driving The Prothrombin Complex Concentrate Market Growth?
The prothrombin complex concentratemarket covered in this report is segmented –
1) By Product: 3-Factor Prothrombin Complex Concentrates; 4-Factor Prothrombin Complex Concentrates; Other Products
2) By Indication: Haemorrhagic Episodes In Factor IX Deficiency (Haemophilia B); Trauma; Life-Threatening Coagulopathy With Acute Bleeding; Warfarin-Associated Acute, Life-Threatening Bleeding; Non-Warfarin Anticoagulant Reversal With Acute Bleeding
3) By Route Of Administration: Intravenous; Subcutaneous; Intramuscular
4) By End-Use: Hospital And Ambulatory Surgical Centers; Specialty Clinics; Other End Users
Subsegments:
1) By Type: Low-Dose 3-Factor Prothrombin Complex Concentrates (PCC); High-Dose 3-Factor Prothrombin Complex Concentrates (PCC); Lyophilized 3-Factor Prothrombin Complex Concentrates (PCC)
2) By Type: Low-Dose 4-Factor Prothrombin Complex Concentrates (PCC); High-Dose 4-Factor Prothrombin Complex Concentrates (PCC); Activated 4-Factor Prothrombin Complex Concentrates (PCC)
3) By Type: Recombinant Coagulation Factor Complexes; Plasma-Derived Coagulation Factor Complexes; Combination Therapy Products
Which Market Trends Are Creating New Opportunities In The Prothrombin Complex Concentrate Industry?
Leading companies in the prothrombin complex concentrate market are developing innovative formulations, such as lyophilized powder, to enhance stability, improve storage, and simplify administration. This lyophilized powder is a freeze-dried formulation designed to remove water, thereby increasing shelf life and maintaining potency. This advancement facilitates better storage conditions and rapid reconstitution for emergency use. For instance, in July 2023, Octapharma USA Inc., a US-based biotechnology company, received FDA approval for Balfaxar, a four-factor prothrombin complex concentrate (4F-PCC) intended for urgent warfarin reversal in surgeries and invasive procedures. This approval was based on the LEX-209 trial, which demonstrated 94.6% hemostatic efficacy, proving it as effective as Kcentra. This progress underscores the industry’s focus on improving coagulation therapies to enhance patient outcomes in critical care settings.
Which Leading Players Are Enhancing Their Prothrombin Complex Concentrate Market Presence Worldwide?
Major companies operating in the prothrombin complex concentrate market are Pfizer Inc., Bristol-Myers Squibb Company, Takeda Pharmaceutical Company Limited, Novo Nordisk A/S, CSL Behring GmbH, Intas Pharmaceuticals Ltd, Baxter International Inc, Grifols S.A., Octapharma AG, Kedrion S.p.A, Haemonetics Corporation, Green Cross Corporation, Shanghai RAAS Blood Products Co. Ltd, Emergent BioSolutions, LFB Group, Hualan Biological Engineering Chongqing Co. Ltd., Sanquin Blood Supply Foundation, Bio Products Laboratory Ltd (BPL), Prothya Biosolutions B.V., China Biologic Products Holdings Inc.
Download The Full Report For Exclusive Market Findings:
How Is Prothrombin Complex Concentrate Market Demand Varying Across Different Regions?
North America was the largest region in the prothrombin complex concentrate market in 2024. The regions covered in the prothrombin complex concentrate market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Version Of The Prothrombin Complex Concentrate Market Report:
https://www.thebusinessresearchcompany.com/customise?id=23488&type=smp
Browse Through More Reports Similar to the Global Prothrombin Complex Concentrate Market 2025, By The Business Research Company
Gastrointestinal Bleeding Treatment Devices Global Market Report 2025
Bleeding Disorders Treatment Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/bleeding-disorders-treatment-global-market-report
Cyclic Heavy Menstrual Bleeding Global Market Report 2025
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model